Ni‐Chun Tsai

Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma

Robert Chen, Joycelynne Palmer, Sandra H. Thomas et al. · Blood · 2012 · 131 citations · Full text

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Matthew Mei, Hun Ju Lee, Joycelynne Palmer et al. · Blood · 2022 · 107 citations · Full text

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia

Anthony S. Stein, Joycelynne Palmer, Ni‐Chun Tsai et al. · Biology of Blood and Marrow Transplantation · 2017 · 95 citations · Full text

Hematological Malignancy, Cell Therapy, Transplantation +14

Factors Affecting Survival in Patients with Anal Melanoma

Yale D. Podnos, Ni‐Chun Tsai, David Smith et al. · The American Surgeon · 2006 · 87 citations

Surgical Oncology, Anal Melanomas, Medicine +12

HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma (NHL)

Amrita Krishnan, Joycelynne Palmer, John A. Zaia et al. · Biology of Blood and Marrow Transplantation · 2010 · 72 citations · Full text

Translational Medicine, Conventional Chemotherapy, Transplantation +15